FDA 483 - Ercros S.A. - November 22, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Ercros Industrial S.A., a sterile drug substance manufacturer in Aranjuez, Spain, was cited for significant deficiencies in its aseptic processing, environmental monitoring, and quality control systems. The inspection revealed issues including inadequate continuous air monitoring, flawed aseptic process simulations, insufficient investigation of particle alarms and visible particles, and poor airflow studies. Additionally, the firm failed to prevent a deviated batch from release testing and lacked proper stability studies for intermediates and disinfection system validation.
ID · 0aa7f14b-c99e-4b00-87a5-7a1cd52c2e84